Concepedia

A. Hagey

AH

9

Publications

496

Citations

9

H-Index

2005

Active since

Affiliations

Abbott Fund(Current)

National Cancer Institute

Center for Cancer Research

The University of Texas MD Anderson Cancer Center

University of Pennsylvania

A. Hagey is an author at Abbott Fund specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

2005–2012

9

Publications

9

A Phase II Study of ABT-751 in Patients with Advanced Non-small Cell Lung Cancer

Ann M. Mauer, Ezra E.W. Cohen, C. Patrick et al. · Journal of Thoracic Oncology · 2008 · 88 citations · Full text

, , +6

The Pharmacokinetics and Safety of ABT-751, a Novel, Orally Bioavailable Sulfonamide Antimitotic Agent: Results of a Phase 1 Study

Kenneth R. Hande, A. Hagey, Jordan Berlin et al. · Clinical Cancer Research · 2006 · 81 citations

Phase 1 Study of ABT-751, a Novel Microtubule Inhibitor, in Patients with Refractory Hematologic Malignancies

Karen Yee, A. Hagey, Srđan Verstovšek et al. · Clinical Cancer Research · 2005 · 79 citations

A Phase 1 Study of ABT-751, an Orally Bioavailable Tubulin Inhibitor, Administered Daily for 7 Days Every 21 Days in Pediatric Patients with Solid Tumors

Elizabeth Fox, John M. Maris, Brigitte C. Widemann et al. · Clinical Cancer Research · 2006 · 62 citations

A Phase I Trial and in vitro Studies Combining ABT-751 with Carboplatin in Previously Treated Non-Small Cell Lung Cancer Patients

Tian Ma, Alexander D. Fuld, James R. Rigas et al. · Chemotherapy · 2012 · 56 citations · Full text

Rows per page

1–5 of 9